ATE18667T1 - Aethenylimidazol-derivate, verfahren zu deren herstellung und deren pharmazeutische zusammensetzungen, bei deren herstellung verwendbare zwischenprodukte und verfahren zu deren herstellung. - Google Patents

Aethenylimidazol-derivate, verfahren zu deren herstellung und deren pharmazeutische zusammensetzungen, bei deren herstellung verwendbare zwischenprodukte und verfahren zu deren herstellung.

Info

Publication number
ATE18667T1
ATE18667T1 AT81201040T AT81201040T ATE18667T1 AT E18667 T1 ATE18667 T1 AT E18667T1 AT 81201040 T AT81201040 T AT 81201040T AT 81201040 T AT81201040 T AT 81201040T AT E18667 T1 ATE18667 T1 AT E18667T1
Authority
AT
Austria
Prior art keywords
production
carbon atoms
processes
group
formula
Prior art date
Application number
AT81201040T
Other languages
English (en)
Inventor
Piet Johannes Akkerboom
Der Stelt Cornelis Van
Bernardus Wegman
Original Assignee
Gist Brocades Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades Nv filed Critical Gist Brocades Nv
Application granted granted Critical
Publication of ATE18667T1 publication Critical patent/ATE18667T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91Nitro radicals
    • C07D233/92Nitro radicals attached in position 4 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91Nitro radicals
    • C07D233/92Nitro radicals attached in position 4 or 5
    • C07D233/93Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by halogen atoms, attached to other ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91Nitro radicals
    • C07D233/92Nitro radicals attached in position 4 or 5
    • C07D233/94Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to other ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503Five-membered rings
    • C07F9/6506Five-membered rings having the nitrogen atoms in positions 1 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT81201040T 1980-09-17 1981-09-16 Aethenylimidazol-derivate, verfahren zu deren herstellung und deren pharmazeutische zusammensetzungen, bei deren herstellung verwendbare zwischenprodukte und verfahren zu deren herstellung. ATE18667T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8005204A NL8005204A (nl) 1980-09-17 1980-09-17 Ethenyl-imidazool-derivaten met antimycotische werkzaamheid.
EP81201040A EP0049913B1 (de) 1980-09-17 1981-09-16 Äthenylimidazol-Derivate, Verfahren zu deren Herstellung und deren pharmazeutische Zusammensetzungen, bei deren Herstellung verwendbare Zwischenprodukte und Verfahren zu deren Herstellung

Publications (1)

Publication Number Publication Date
ATE18667T1 true ATE18667T1 (de) 1986-04-15

Family

ID=19835894

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81201040T ATE18667T1 (de) 1980-09-17 1981-09-16 Aethenylimidazol-derivate, verfahren zu deren herstellung und deren pharmazeutische zusammensetzungen, bei deren herstellung verwendbare zwischenprodukte und verfahren zu deren herstellung.

Country Status (10)

Country Link
EP (1) EP0049913B1 (de)
JP (1) JPS6030673B2 (de)
AT (1) ATE18667T1 (de)
DE (1) DE3174132D1 (de)
DK (1) DK412581A (de)
ES (4) ES8305729A1 (de)
GR (1) GR75347B (de)
IE (1) IE52055B1 (de)
NL (1) NL8005204A (de)
PT (1) PT73659B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2128606B (en) * 1979-11-13 1984-10-31 Sandoz Ltd Oxiranes
GR78234B (de) * 1981-03-10 1984-09-26 Ciba Geigy Ag
CA1206970A (en) * 1981-10-01 1986-07-02 Hak-Foon Chan Substituted ethylenic imidazoles and triazoles
DE3139251A1 (de) * 1981-10-02 1983-04-21 Basf Ag, 6700 Ludwigshafen Mittel zur regulierung des pflanzenwachstums
EP0091503A1 (de) * 1982-04-14 1983-10-19 Gist-Brocades N.V. Verfahren zur Bekämpfung von fungiziden Infektionen
US4539325A (en) * 1983-11-07 1985-09-03 Janssen Pharmaceutica N.V. 1-(2-Aryl-2-halo-1-ethenyl)-1H-azoles, and anticonvulsant use thereof
GB8511344D0 (en) * 1985-05-03 1985-06-12 Ici Plc Heterocyclic compounds
JPS6348214A (ja) * 1986-08-18 1988-02-29 Morishita Seiyaku Kk 1−〔2−(2,4−ジクロロフエニル)−3−メチル−1−ペンテニル〕−1h−イミダゾ−ルを含有する水中油型脂肪乳剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1486817A (fr) * 1965-07-22 1967-06-30 Basf Ag Insecticides
NL7110875A (de) * 1970-08-13 1972-02-15
DE2862340D1 (en) * 1978-02-01 1983-11-24 Wellcome Found Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations thereof
IT1098864B (it) * 1978-09-19 1985-09-18 Farchemia Spa Processo per la preparazione di nitroimidazoli

Also Published As

Publication number Publication date
JPS5781469A (en) 1982-05-21
JPS6030673B2 (ja) 1985-07-17
ES8306999A1 (es) 1983-06-16
ES516553A0 (es) 1983-06-16
EP0049913A2 (de) 1982-04-21
IE52055B1 (en) 1987-05-27
DK412581A (da) 1982-03-18
ES516554A0 (es) 1983-06-16
ES8307000A1 (es) 1983-06-16
DE3174132D1 (en) 1986-04-24
IE812146L (en) 1982-03-17
PT73659A (en) 1981-10-01
ES505563A0 (es) 1983-04-16
GR75347B (de) 1984-07-13
EP0049913A3 (en) 1982-10-06
PT73659B (en) 1985-06-28
ES8307001A1 (es) 1983-06-16
ES8305729A1 (es) 1983-04-16
ES516552A0 (es) 1983-06-16
EP0049913B1 (de) 1986-03-19
NL8005204A (nl) 1982-04-16

Similar Documents

Publication Publication Date Title
DE3873612D1 (de) Dithioacetal-verbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
FI892787A0 (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-indolyylialkyyli-4-(substituoitu pyridinyyli)piperatsiinien valmistamiseksi
DE69129175D1 (de) 1-Methylcarbapenemderivate und Verfahren zu ihrer Herstellung
AT389108B (de) Neue pyridazinonderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
ATE91682T1 (de) Alkansulfonanilid-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung.
ATE18667T1 (de) Aethenylimidazol-derivate, verfahren zu deren herstellung und deren pharmazeutische zusammensetzungen, bei deren herstellung verwendbare zwischenprodukte und verfahren zu deren herstellung.
ATE67199T1 (de) Benzoxazin-derivate und verfahren zu ihrer herstellung.
ATE75737T1 (de) Indenothiazolderivate und verfahren zu ihrer herstellung.
PT76614B (de) Thiomethylpyridin-derivate verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
ATE35133T1 (de) N-substituierte (bis(hydroxymethyl)-methyl>isochinolinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten.
ATE59637T1 (de) Neue basisch substituierte pyridinverbindungen, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung.
ATE7137T1 (de) Nitrosoureum-derivate, verfahren zu deren herstellung, und diese enthaltende pharmazeutische zusammensetzungen.
ATE18556T1 (de) Phenylalkyloxirancarbonsaeuren, verfahren zu ihrer herstellung, ihre anwendung und sie enthaltende arzneimittel.
ATE52509T1 (de) Thiazolidinderivate und verfahren zu ihrer herstellung.
ATE19879T1 (de) Furyloxazolylessigsaeure-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE30911T1 (de) Hydrazinopyridazinverbindung, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE36321T1 (de) (bis(substituiertes methyl)methyl>isochinolinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten.
ES8105286A1 (es) Un procedimiento para la preparacion de nuevos derivados de dihidropiridina.
ATE2075T1 (de) Oxazolin- und thiazolin-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
DE68926016T2 (de) Halogeno-4-Methylpyrazole und Verfahren zu ihrer Herstellung
ATE1585T1 (de) Clavulansaeurederivate, ihre herstellung und sie enthaltende pharmazeutische praeparate.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee